(Q37994123)

26 August 2017

title

A review and critical analysis of professional societies' guidelines for pharmacologic management of type 2 diabetes mellitus (English)

1 reference

26 August 2017

0 references

1 reference

Robert A Vigersky

1

1 reference

26 August 2017

publication date

1 June 2012

1 reference

26 August 2017

published in

Current diabetes report

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

246-254

1 reference

Projecting the future diabetes population size and related costs for the U.S.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

National trends in treatment of type 2 diabetes mellitus, 1994-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0262-Y

The Endocrine Society Ethics Advisory Committee: ethical aspects of conflicts of interests, October 2003

21 January 2018

1 reference

12 December 2020

Medication costs, adherence, and health outcomes among Medicare beneficiaries

1 reference

12 December 2020

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan

1 reference

12 December 2020

Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations

1 reference

12 December 2020

Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study

1 reference

12 December 2020

Conflicts of interest in cardiovascular clinical practice guidelines

1 reference

12 December 2020

Group based training for self-management strategies in people with type 2 diabetes mellitus

1 reference

12 December 2020

10.1007/S11892-012-0262-Y

Identifiers

DOI

1 reference

26 August 2017

1 reference